Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Defactinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031747822/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009704485/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer

    29 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240729473398/en

    BUSINESSWIRE
    29 Jul 2024
    Share Share
    Verastem's begins rolling sub of NDA to USFDA of avutometinib & defactinib combo
    Verastem's begins rolling sub of NDA to USFDA of avutometinib & defactinib combo

    28 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169383&sid=2

    PHARMABIZ
    28 May 2024
    Share Share
    Verastem Nda Initiation: Avutometinib Defactinib Combo Rolling Submission
    Verastem Nda Initiation: Avutometinib Defactinib Combo Rolling Submission

    24 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240524990712/en

    BUSINESSWIRE
    24 May 2024
    Share Share
    Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone
    Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305616374/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share